YUNGJIN PHARM. CO., LTD Logo

YUNGJIN PHARM. CO., LTD

003520 | KO

Overview

Corporate Details

ISIN(s):
KR7003520004
LEI:
Country:
South Korea
Address:
서울특별시 송파구 올림픽로35다길 13 국민연금 잠실사옥 2~3층, 송파구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

No description available.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-28 00:00
Regulatory Filings
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 6.1 KB
2025-08-14 00:00
Annual Report
[기재정정]사업보고서 (2024.12)
Korean 1.2 MB
2025-08-14 00:00
Quarterly Report
[기재정정]분기보고서 (2025.03)
Korean 695.0 KB
2025-08-14 00:00
Interim / Quarterly Report
반기보고서 (2025.06)
Korean 879.7 KB
2025-08-13 00:00
Environmental & Social Information
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 11.1 KB
2025-08-01 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-07-31 00:00
Regulatory Filings
[기재정정]단일판매ㆍ공급계약체결
Korean 12.9 KB
2025-07-25 00:00
Share Issue/Capital Change
[기재정정]신규시설투자등
Korean 13.7 KB
2025-05-30 00:00
Major Shareholding Notification
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Korean 90.6 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 681.6 KB
2025-05-07 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.3 KB
2025-03-28 00:00
AGM Information
정기주주총회결과
Korean 33.7 KB
2025-03-28 00:00
Board/Management Information
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.7 KB
2025-03-20 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.2 MB
2025-03-12 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 492.1 KB

Automate Your Workflow. Get a real-time feed of all YUNGJIN PHARM. CO., LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for YUNGJIN PHARM. CO., LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for YUNGJIN PHARM. CO., LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

INOVIO PHARMACEUTICALS, INC. Logo
Develops DNA medicines delivered via smart devices for cancer, HPV, and infectious diseases.
United States of America
INO
INSMED Inc Logo
Develops and commercializes innovative therapies for serious and rare diseases.
United States of America
INSM
Instil Bio, Inc. Logo
Developing autologous TIL cell therapies using a patient's own immune cells to fight solid tumors.
United States of America
TIL
INTENSITY THERAPEUTICS, INC. Logo
Develops injected therapies to kill tumors locally and activate a systemic immune response.
United States of America
INTS
Intercure Ltd. Logo
Develops and distributes pharmaceutical-grade medical cannabis for patients and pharmacies globally.
Israel
INCR
Intervacc AB Logo
Develops recombinant protein vaccines and diagnostics for animal health, like Strangvac® for horses.
Sweden
IVACC
iNtRON Biotechnology, Inc. Logo
Develops phage therapeutics and molecular diagnostics to combat infectious diseases.
South Korea
048530
Inventiva Logo
Clinical-stage biopharma developing oral therapies for fibrosis, oncology, & lysosomal disorders.
France
IVA
Inventiva S.A. Logo
Develops oral small molecule therapies for NASH, fibrosis, and rare metabolic disorders.
United States of America
IVA
Invivyd, Inc. Logo
Develops evolution-resistant antibodies to protect against viral diseases like COVID-19 and flu.
United States of America
IVVD

Talk to a Data Expert

Have a question? We'll get back to you promptly.